These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 9273359

  • 1. Functional impairment of bronchoalveolar lavage phospholipids in early Pneumocystis carinii pneumonia in rats.
    Su TH, Natarajan V, Kachel DL, Moxley MA, Longmore WJ, Martin WJ.
    J Lab Clin Med; 1996 Mar; 127(3):263-71. PubMed ID: 9273359
    [Abstract] [Full Text] [Related]

  • 2. Surfactant phospholipids and lavage phospholipase A2 in experimental Pneumocystis carinii pneumonia.
    Sheehan PM, Stokes DC, Yeh YY, Hughes WT.
    Am Rev Respir Dis; 1986 Sep; 134(3):526-31. PubMed ID: 3489425
    [Abstract] [Full Text] [Related]

  • 3. Surfactant analysis during Pneumocystis carinii pneumonia in HIV-infected patients.
    Escamilla R, Prevost MC, Hermant C, Caratero A, Cariven C, Krempf M.
    Chest; 1992 Jun; 101(6):1558-62. PubMed ID: 1600773
    [Abstract] [Full Text] [Related]

  • 4. Reduction of pulmonary surfactant in patients with human immunodeficiency virus infection and Pneumocystis carinii pneumonia.
    Hoffman AG, Lawrence MG, Ognibene FP, Suffredini AF, Lipschik GY, Kovacs JA, Masur H, Shelhamer JH.
    Chest; 1992 Dec; 102(6):1730-6. PubMed ID: 1446480
    [Abstract] [Full Text] [Related]

  • 5. Surfactant protein-A levels increase during Pneumocystis carinii pneumonia in the rat.
    Phelps DS, Umstead TM, Rose RM, Fishman JA.
    Eur Respir J; 1996 Mar; 9(3):565-70. PubMed ID: 8730021
    [Abstract] [Full Text] [Related]

  • 6. Regulation of surfactant phosphatidylcholine secretion from alveolar type II cells during Pneumocystis carinii pneumonia in the rat.
    Rice WR, Singleton FM, Linke MJ, Walzer PD.
    J Clin Invest; 1993 Dec; 92(6):2778-82. PubMed ID: 8254031
    [Abstract] [Full Text] [Related]

  • 7. Pneumocystis carinii pneumonia in HIV-infected patients: effect of steroid therapy on surfactant level.
    Dichter JR, Lundgren JD, Nielsen TL, Jensen BN, Schattenkerk J, Benfield TL, Lawrence M, Shelhamer J.
    Respir Med; 1999 Jun; 93(6):373-8. PubMed ID: 10464817
    [Abstract] [Full Text] [Related]

  • 8. Abnormal lipid composition of bronchoalveolar lavage fluid obtained from individuals with AIDS-related lung disease.
    Rose RM, Catalano PJ, Koziel H, Furlong ST.
    Am J Respir Crit Care Med; 1994 Feb; 149(2 Pt 1):332-8. PubMed ID: 8306026
    [Abstract] [Full Text] [Related]

  • 9. Effect of bronchoalveolar lavage fluid from Pneumocystis carinii-infected hosts on phagocytic activity of alveolar macrophages.
    Lasbury ME, Lin P, Tschang D, Durant PJ, Lee CH.
    Infect Immun; 2004 Apr; 72(4):2140-7. PubMed ID: 15039336
    [Abstract] [Full Text] [Related]

  • 10. Follow-up bronchoalveolar lavage in AIDS patients with Pneumocystis carinii pneumonia. Pneumocystis carinii burden predicts early relapse.
    Colangelo G, Baughman RP, Dohn MN, Frame PT.
    Am Rev Respir Dis; 1991 May; 143(5 Pt 1):1067-71. PubMed ID: 1708950
    [Abstract] [Full Text] [Related]

  • 11. Pneumocystis carinii alters surfactant protein A concentrations in bronchoalveolar lavage fluid.
    Sternberg RI, Whitsett JA, Hull WM, Baughman RP.
    J Lab Clin Med; 1995 Apr; 125(4):462-9. PubMed ID: 7706901
    [Abstract] [Full Text] [Related]

  • 12. Phospholipase activities of bronchoalveolar lavage fluid in rat Pneumocystis carinii pneumonia.
    Kernbaum S, Masliah J, Alcindor LG, Bouton C, Christol D.
    Br J Exp Pathol; 1983 Feb; 64(1):75-80. PubMed ID: 6601489
    [Abstract] [Full Text] [Related]

  • 13. Surfactant protein D-mediated aggregation of Pneumocystis carinii impairs phagocytosis by alveolar macrophages.
    Yong SJ, Vuk-Pavlovic Z, Standing JE, Crouch EC, Limper AH.
    Infect Immun; 2003 Apr; 71(4):1662-71. PubMed ID: 12654779
    [Abstract] [Full Text] [Related]

  • 14. [Spontaneously healed P. carinii pneumonia in the course of steroid therapy for interstitial pneumonia--many trophozoites in bronchoalveolar lavage].
    Sato S, Suwabe A, Osanai K, Kudo Y, Kato S, Takahashi H, Higuchi J, Takahashi K, Tomoike H.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 May; 31(5):636-42. PubMed ID: 8331852
    [Abstract] [Full Text] [Related]

  • 15. Phospholipid composition of Pneumocystis carinii carinii and effects of methylprednisolone immunosuppression on rat lung lipids.
    Guo Z, Kaneshiro ES.
    Infect Immun; 1995 Apr; 63(4):1286-90. PubMed ID: 7890386
    [Abstract] [Full Text] [Related]

  • 16. Alteration of surfactant proteins A and D in bronchoalveolar lavage fluid of Pneumocystis carinii pneumonia.
    Qu J, He L, Rong Z, Pan J, Chen X, Morrison DC, Li X.
    Chin Med J (Engl); 2001 Nov; 114(11):1143-6. PubMed ID: 11729507
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of interleukin-8 in AIDS-associated Pneumocystis carinii pneumonia.
    Benfield TL, Vestbo J, Junge J, Nielsen TL, Jensen AB, Lundgren JD.
    Am J Respir Crit Care Med; 1995 Apr; 151(4):1058-62. PubMed ID: 7697231
    [Abstract] [Full Text] [Related]

  • 18. Pulmonary inflammation disrupts surfactant function during Pneumocystis carinii pneumonia.
    Wright TW, Notter RH, Wang Z, Harmsen AG, Gigliotti F.
    Infect Immun; 2001 Feb; 69(2):758-64. PubMed ID: 11159965
    [Abstract] [Full Text] [Related]

  • 19. Pro-inflammatory cytokines in lung and blood during steroid-induced Pneumocystis carinii pneumonia in rats.
    Perenboom RM, Beckers P, Van Der Meer JW, Van Schijndel AC, Oyen WJ, Corstens FH, Sauerwein RW.
    J Leukoc Biol; 1996 Dec; 60(6):710-5. PubMed ID: 8975872
    [Abstract] [Full Text] [Related]

  • 20. 120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A.
    Zimmerman PE, Voelker DR, McCormack FX, Paulsrud JR, Martin WJ.
    J Clin Invest; 1992 Jan; 89(1):143-9. PubMed ID: 1530850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.